Mavens Biotech Ltd - Stock Valuation and Financial Performance

BSE: 590083 | NSE: | Trading | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Mavens Biotech

M-Cap below 100cr DeciZen not available

Mavens Biotech stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
5.2 Cr.
52-wk low:
0.5
52-wk high:
0.5

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Mavens Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0.4%0.7%0.4%0.1%-14.4%-41.4%-13.7%-2.3%-2.6%-2.1%-
Value Creation
Index
-1.0-1.0-1.0-1.0-2.0-4.0-2.0-1.2-1.2-1.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.81.10.810.2000000
Sales YoY Gr.-29.3%-21.7%15.7%-81.3%-100%NANANANA-
Adj EPS 0000-0.2-0.3-0.1-0-0-0-0
YoY Gr.-0%0%-100%NANANANANANA-
BVPS (₹) 1.71.71.81.80.90.60.50.50.50.51.8
Adj Net
Profit
0.10.10.10-2.1-3.4-0.8-0.1-0.1-0.10
Cash Flow from Ops. 0-0.10-0.1-0.200000-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%NANA
Adj EPS -200%NANANA
BVPS-13.1%-11.5%-2%0%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
0.40.70.40.1-14.4-41.4-13.7-2.3-2.6-2.1-0.9
Op. Profit
Mgn %
22.730.732.613.8-1200000015.7
Net Profit
Mgn %
8.311.910.12.3-1194.200000-INF
Debt to
Equity
0000000000-
Working Cap
Days
5,5674,4015,7555,05318,5530000097
Cash Conv.
Cycle
3,2511,3271001311,7580000035

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Mavens Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) -0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 1.8 -
Reserves (₹ Cr.) 8 -
P/BV 0.27 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.47 / 0.47
All Time Low / High (₹) 0.40 / 174.95
Market Cap (₹ Cr.) 5.2
Equity (₹ Cr.) 11
Face Value (₹) 1
Industry PE 77.6

Management X-Ray of Mavens Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Mavens Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales0.821.060.830.960.1800000
Operating Expenses 0.630.730.560.820.502.220.400.150.150.17
Manufacturing Costs0.010.040.020.02000000
Material Costs0.04000.370.110.440000
Employee Cost 0.210.240.220.210.120.090.070.070.070.07
Other Costs 0.370.450.310.220.271.680.320.080.080.10
Operating Profit 0.190.330.270.13-0.33-2.22-0.40-0.15-0.15-0.17
Operating Profit Margin (%) 22.7%30.7%32.6%13.8%-185.0%-----
Other Income 0.110.08000.050.020.020.020.010
Interest 0000000000
Depreciation 0.220.280.150.100.070.020.01000
Exceptional Items 0000-1.84-1.24-0.46000.19
Profit Before Tax 0.070.130.120.03-2.19-3.46-0.84-0.13-0.140.02
Tax 0.0100.040.01-0.01-0.060000
Profit After Tax 0.070.130.080.02-2.18-3.40-0.84-0.13-0.140.02
PAT Margin (%) 8.3%11.9%10.1%2.5%-1,240.2%-----
Adjusted EPS (₹)0.00.00.00.0-0.2-0.3-0.10.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 19.1119.1419.2219.259.926.525.685.555.415.43
Share Capital 10.9910.9910.9910.9910.9910.9910.9910.9910.9910.99
Reserves 8.128.158.238.26-1.07-4.47-5.31-5.44-5.58-5.56
Minority Interest0000000000
Debt0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Trade Payables0.070.040.030.02000000
Others Liabilities 0.220.220.260.170.191.020.280.310.280.33
Total Liabilities 19.4119.4019.5119.4410.117.545.965.875.695.76

Fixed Assets

Gross Block7.257.257.267.265.204.114.114.113.190.39
Accumulated Depreciation2.512.883.033.131.260.360.370.370.370.37
Net Fixed Assets4.744.374.224.123.953.753.743.742.820.02
CWIP 1.441.441.441.44000000
Investments 0.420.420.420.451.601.601.601.602.525.51
Inventories2.920000.4400000
Trade Receivables4.560.400.190.620.650.210000
Cash Equivalents 0.250.220.250.120.010.030.010.040.020.01
Others Assets5.0812.5612.9912.693.461.940.610.490.330.22
Total Assets 19.4119.4019.5119.4410.117.545.965.875.695.76

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.02-0.110.04-0.10-0.200-0.040-0.03-0.02
PBT 0.070.130.120.03-0.35-2.22-0.38-0.13-0.14-0.17
Adjustment 0.110.200.150.100.161.600.20-0.02-0.010
Changes in Working Capital -0.2-0.39-0.23-0.240.010.620.140.150.130.15
Tax Paid -0.01-0.0500-0.0100000
Cash Flow From Investing Activity 0.110.08-0.01-0.030.090.020.020.020.010
Capex 00-0.0100.0400000
Net Investments 000-0.03000000
Others 0.110.08000.050.020.020.020.010
Cash Flow From Financing Activity -0.05000000000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others -0.05000000000
Net Cash Flow 0.04-0.030.04-0.13-0.110.02-0.020.03-0.01-0.02
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)0.360.660.440.12-14.94-41.36-13.7-2.29-2.590.34
ROCE (%)0.390.670.640.18-15.03-42.07-13.7-2.29-2.590.34
Asset Turnover Ratio0.040.050.040.050.0100000
PAT to CFO Conversion(x)-0.29-0.850.5-5N/AN/AN/AN/AN/A-1
Working Capital Days
Receivable Days2,0088551291531,31100000
Inventory Days1,31300092400000
Payable Days8220023000000

Mavens Biotech Ltd Stock News

Mavens Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Mavens Biotech on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Mavens Biotech stood at ₹5.17.
The latest P/E ratio of Mavens Biotech as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Mavens Biotech as of 01-Jan-1970 05:30 is 0.27.
The 52-week high of Mavens Biotech is ₹0.47 and the 52-week low is ₹0.47.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mavens Biotech is ₹0.00 ( Cr.) .

About Mavens Biotech Ltd

Mavens Biotech Limited is a public limited company originally incorporated on October 24, 1981 and was initially involved in trading of agricultural and related products.The company went public in the 1982 with 2,48,000 equity shares at par, out of which 1,50,000 equity shares were offered to the public and balance 98,000 equity shares were reserved for Directors, Promoters, their friends, relatives and associates.

Mavens Biotech Ltd. is an integrated plant biotechnology company and operates in the area of bioinformatics, tissue culture and agriculture & food processing based research and development in the Indian biotechnology industry.

Business units of the company are:

Bioinformatics Center - The company has established a bio-informatics center to handle, capture, manage and analyze the large quantities of data produced during research by drugs, pharmaceuticals, health care, foods processing and agriculture related industries which can be used for drug discovery and diagnostics.

Plant Tissue Culture Unit - This SBU includes a well equipped commercial plant tissue culture unit for the production of high market value oriented horticulture and floriculture plant species.

The company is currently developing intellectual property and commercial applications in the area of agricultural bioinformatics, particularly in the analysis and management of extremely large volumes of data generated by high throughput technologies such as microarrays and metabolomics. The Company is working with imaging technology experts to deliver integrated solutions to agribusinesses. The basic reason of undertaking this activity is

  • To undertake projects concerning DNA/protein sequence analysis and their preliminary structural and functional analysis
  • To gather, store and manage in specialized databanks the vast amounts of biological data and analyze them into meaningful information and knowledge.
  • To develop analytical applications that sort and organize the genetic data and systems that will help store and distribute the collected information

The company is active in plant tissue culture, the basic objective of the company to undertake it is

  • To propagate high value plants by tissue culture
  • To introduce new breeds of planting material which in turn would contribute in quality improvement and production of uniform genotypes and true to type disease indexed plants.
  • To develop protocols and upgrade or propagate wide ranges of horticulture and floriculture plant species
  • To accelerate vegetative multiplication and regeneration by controlling nutrient level, light, temperature and other factors

The company’s tissue culture unit is set up off Mumbai – Karjat. Its Infrastructure includes:

  • The commercial laboratory has International Standard Growing Rooms, Clean rooms for production jobs, media preparation room, autoclave etc.
  • The laboratory is secure against all kinds of technical and electrical failures that can be controlled for various temperatures and lighting periods.
  • Green House and Nursery facilities are available for hardening tissue culture plants.
  • For carrying out research and development work in the development of new varieties of planting materials, germplasm of different characteristic of various crops cultivated in different regions are taken. The Nursery has a Gene bank that is responsible for gathering and storing important species of medicinal, aromatic and floral plants.

The company is continuously involved in R & D, that includes

  • Introduction of new breeds
  • Development of economical protocols for commercial micropropagation and plant genetic engineering
  • Research work for development / introduction of transgenic plant material and new cultivars in horticulture and floriculture biotechnology

Services offered by the company on Bioinformatics-

  • Patent Information
  • Sequence Analysis
  • Software Development
  • Bibliography
  • Web Services

Services offered in Plant Tissue Culture includes-

  • Contract propagation
  • Supplying of wide range of horticulture plant, hardened plants and bulbs,
  • Embryoculture
  • Somatic Embryogenesis
  • Keeping stock of breeding and parent lines
  • Protocol development and selection
  • Mutation induction in tissue culture

Products being offered are -

  • Ornamental Plants
  • Medicinal Plants
  • Banana
  • Sugarcane
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.